Products 105816-06-6

CAS 105816-06-6 appears in our catalog under these names: Nateglinide Impurity 6 (Nateglinide EP Impurity C), (2R)-2-[[Oxo-(4-propan-2-ylcyclohexyl)methyl]amino]-3-phenylpropanoic acid, 95%, Nateglinide EP Impurity C (Nateglinide USP Related Compound C), Nateglinide EP Impurity C, N-((cis-4-(1-Methylethyl)cyclohexyl)carbonyl)-D-phenylalanine(Nateglinide Impurity). Offered by: Hubei YoungXin, Combi-blocks, Chemat Brand, TRC, Biosynth. Available pack sizes: 10mg, 25mg, 50mg, 100mg, 200mg, 250mg, 500mg, on request.

Nateglinide Impurity 6 (Nateglinide EP Impurity C)
Hubei YoungXin
  • size: 10mg, 25mg, 50mg, 100mg
  • Variants: 5
View product
(2R)-2-[[Oxo-(4-propan-2-ylcyclohexyl)methyl]amino]-3-phenylpropanoic acid, 95%
Combi-blocks
  • size: 250mg, 500mg
  • Variants: 2
View product
Nateglinide EP Impurity C (Nateglinide USP Related Compound C)
Chemat Brand
  • size: on request
  • Variants: 1
View product
Nateglinide EP Impurity C
Chemat Brand
  • size: on request
  • Variants: 1
View product
N-((cis-4-(1-Methylethyl)cyclohexyl)carbonyl)-D-phenylalanine(Nateglinide Impurity)
TRC, Biosynth
  • size: 250mg, 50mg, 25mg
  • Variants: 3
View product
NATEGLINIDE RELATED COMPOUND C
Sigma-Aldrich
  • size: 20MG
  • Variants: 1
from 5267.00
View product
Structural formula: {0} (CAS {1})

Nateglinide is an N-acyl-D-phenylalanine resulting from the formal condensation of the amino group of D-phenylalanine with the carboxy group of trans-4-isopropylcyclohexanecarboxylic acid. An orally-administered, rapidly-absorbed, short-acting insulinotropic agent, it is used for the treatment of type 2 diabetes mellitus. It has a role as a hypoglycemic agent and an EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor.

Source: ChEBI

Identity
Molecular formulaC19H27NO3
Molecular weight317.4 g/mol
IUPAC name(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid
InChIKeyOELFLUMRDSZNSF-OFLPRAFFSA-N
SMILESCC(C)C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)O

Computed by PubChem (NCBI)

Synonyms: nateglinide, Starlix, Starsis, senaglinide, Fastic, Trazec, D-Nateglinide, nateglinida, nateglinidum, (-)-N-(trans-4-Isopropylcyclohexanecarbonyl)-D-phenylalanine
Related forms of this compound
(2S)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid C19H27NO3
3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid C19H27NO3
(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid C19H27NO3
(2R)-3-(2,3,4,5,6-pentadeuteriophenyl)-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid C19H27NO3
Isomers (same molecular formula)
(3S,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one C19H27NO3
tert-butyl 5-methoxyspiro[1,2-dihydroindene-3,4'-piperidine]-1'-carboxylate C19H27NO3
(3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one C19H27NO3
9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one C19H27NO3
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxylic acid C19H27NO3
(3aS,3bS,5aR,9aR,9bS,11aS)-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxylic acid C19H27NO3
tert-butyl 6-(3-ethyl-4-hydroxyphenyl)-3-methyl-3,4-dihydro-2H-pyridine-1-carboxylate C19H27NO3
(8-propan-2-yl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate C19H27NO3